{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ANCHOR and MD simulation", "Caulerpin", "Molecular docking", "SARS-CoV-2", "Simeprevir"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "32837118", "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "07", "Day": "23"}], "Language": ["eng"], "ELocationID": ["10.1007/s11224-020-01586-w"], "Journal": {"ISSN": "1040-0400", "JournalIssue": {"Volume": "31", "Issue": "6", "PubDate": {"Year": "2020"}}, "Title": "Structural chemistry", "ISOAbbreviation": "Struct Chem"}, "ArticleTitle": "Destabilizing the structural integrity of COVID-19 by caulerpin and its derivatives along with some antiviral drugs: An in silico approaches for a combination therapy.", "Pagination": {"StartPage": "2391", "EndPage": "2412", "MedlinePgn": "2391-2412"}, "Abstract": {"AbstractText": ["Presently, the SARS-CoV-2 (COVID-19) pandemic has been spreading throughout the world. Some drugs such as lopinavir, simeprevir, hydroxychloroquine, chloroquine, and amprenavir have been recommended for COVID-19 treatment by some researchers, but these drugs were not effective enough against this virus. This study based on in silico approaches was aimed to increase the anti-COVID-19 activities of these drugs by using caulerpin and its derivatives as an adjunct drug against SARS-CoV-2 receptor proteins: the SARS-CoV-2 main protease and the SARS-CoV-2 spike protein. Caulerpin exhibited antiviral activities against chikungunya virus and herpes simplex virus type 1. Caulerpin and some of its derivatives showed inhibitory activity against Alzheimer's disease. The web server ANCHOR revealed higher protein stability for the two receptors with disordered score (<\u20090.6). Molecular docking analysis showed that the binding energies of most of the caulerpin derivatives were higher than all the suggested drugs for the two receptors. Also, we deduced that inserting NH<sub>2</sub>, halogen, and vinyl groups can increase the binding affinity of caulerpin toward 6VYB and 6LU7, while inserting an alkyl group decreases the binding affinity of caulerpin toward 6VYB and 6LU7. So, we can modify the inhibitory effect of caulerpin against 6VYB and 6LU7 by inserting NH<sub>2</sub>, halogen, and vinyl groups. Based on the protein disordered results, the SARS-CoV-2 main protease and SARS-CoV-2 spike protein domain are highly stable proteins, so it is quite difficult to unstabilize their integrity by using individual drugs. Also, molecular dynamics (MD) simulation indicates that binding of the combination therapy of simeprevir and the candidate studied compounds to the receptors was stable and had no major effect on the flexibility of the protein throughout the simulations and provided a suitable basis for our study. So, this study suggested that caulerpin and its derivatives could be used as a combination therapy along with lopinavir, simeprevir, hydroxychloroquine, chloroquine, and amprenavir for disrupting the stability of SARS-CoV2 receptor proteins to increase the antiviral activity of these drugs."], "CopyrightInformation": "\u00a9 Springer Science+Business Media, LLC, part of Springer Nature 2020."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.411662.6", "0000 0004 0412 4932"], "Affiliation": "Department of Chemistry, Faculty of Science, Beni-Suef University, Beni Suef, 62511 Egypt."}], "LastName": "Ahmed", "ForeName": "Shimaa A", "Initials": "SA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.411662.6", "0000 0004 0412 4932"], "Affiliation": "Department of Chemistry, Faculty of Science, Beni-Suef University, Beni Suef, 62511 Egypt."}], "LastName": "Abdelrheem", "ForeName": "Doaa A", "Initials": "DA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.411662.6", "0000 0004 0412 4932"], "Affiliation": "Micro-analysis and Environmental Research and Community Services Center, Faculty of Science, Beni-Suef University, Beni Suef, Egypt."}], "LastName": "El-Mageed", "ForeName": "H R Abd", "Initials": "HRA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.411662.6", "0000 0004 0412 4932"], "Affiliation": "Research Institute of Medicinal and Aromatic Plants (RIMAP), Beni-Suef University, Beni Suef, Egypt."}], "LastName": "Mohamed", "ForeName": "Hussein S", "Initials": "HS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.412656.2", "0000 0004 0451 7306"], "Affiliation": "Department of Pharmacy, University of Rajshahi, Rajshahi, 6205 Bangladesh."}], "LastName": "Rahman", "ForeName": "Aziz A", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.411662.6", "0000 0004 0412 4932"], "Affiliation": "Department of Botany, Faculty of Science, Beni-Suef University, Beni-Suef, 62511 Egypt."}], "LastName": "Elsayed", "ForeName": "Khaled N M", "Initials": "KNM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.411662.6", "0000 0004 0412 4932"], "Affiliation": "Department of Chemistry, Faculty of Science, Beni-Suef University, Beni Suef, 62511 Egypt."}], "LastName": "Ahmed", "ForeName": "Sayed A", "Initials": "SA"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Struct Chem", "NlmUniqueID": "101582397", "ISSNLinking": "1040-0400"}, "CoiStatement": "Conflict of interestThe authors declare that they have no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "de Oliveira MD, de Oliveira KM. Comparative computational study of SARS-CoV-2 receptors antagonists from already approved drugs. Cep. 2020;8:7."}, {"Citation": "Shen K, Yang Y, Wang T, Zhao D, Jiang Y, Jin R, Zheng Y, Xu B, Xie Z, Lin L, Shang Y. Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts\u2019 consensus statement. World J Pediatr. 2020;7:1\u20139.", "ArticleIdList": ["PMC7090771", "32034659"]}, {"Citation": "Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727\u2013733.", "ArticleIdList": ["PMC7092803", "31978945"]}, {"Citation": "Wang T, Du Z, Zhu F, Cao Z, An Y, Gao Y, Jiang B. Comorbidities and multi-organ injuries in the treatment of COVID-19. Lancet. 2020;395:52.", "ArticleIdList": ["PMC7270177", "32171074"]}, {"Citation": "Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Yu T. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507\u2013513.", "ArticleIdList": ["PMC7135076", "32007143"]}, {"Citation": "Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;3:269\u2013271.", "ArticleIdList": ["PMC7054408", "32020029"]}, {"Citation": "Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, Guo L, Guo R, Chen T, Hu J, Xiang Z. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun. 2020;11:1\u20132.", "ArticleIdList": ["PMC7100515", "32221306"]}, {"Citation": "Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y, Wang Q, Xu Y, Li M, Li X, Zheng M (2020) Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica B 10:766\u2013788", "ArticleIdList": ["PMC7102550", "32292689"]}, {"Citation": "Boxall ABA. The environmental side effects of medication. EMBO Rep. 2004;5:1110\u20131116.", "ArticleIdList": ["PMC1299201", "15577922"]}, {"Citation": "Angiolella L, Sacchetti G, Efferth T (2018) Antimicrobial and antioxidant activities of natural compounds. Evid Based Complement Alternat Med:1\u20133. 10.1155/2018/1945179", "ArticleIdList": ["PMC6011080", "29977311"]}, {"Citation": "Macedo NRPV, Ribeiro MS, Villa\u00e7a RC, Ferreira W, Pinto AM, Teixeira VL, Cirne-Santos C, Paix\u00e3o ICNP, Giongo V. Caulerpin as a potential antiviral drug against herpes simplex virus type 1. Rev Bras Farmacogn Braz J Pharmacogn. 2012;22:861\u2013867."}, {"Citation": "Ayyad SEN, Badria FA. Caulerpin, an antitumor indole alkaloid from Caulerpa racemosa. Alex J Pharm Sci. 1994;8:217."}, {"Citation": "Xu XH, Su JG. The separation, identification and bioassay of caulerpin. Zhongshan Daxue Xuebao Ziran Kexueban. 1996;35:64\u201366."}, {"Citation": "Libr\u00e1n-P\u00e9rez M, Pereiro P, Figueras A, Novoa B. Antiviral activity of palmitic acid via autophagic flux inhibition in zebrafish (Danio rerio) Fish Shellfish Immunol. 2019;95:595\u2013605.", "ArticleIdList": ["31676430"]}, {"Citation": "Nagappan T, Vairappan CS. Nutritional and bioactive properties of three edible species of green algae, genus Caulerpa (Caulerpaceae) J Appl Phycol. 2014;26(2):1019\u20131027."}, {"Citation": "Mangala SW, Govenkar B. Constituents of Chondria armata. Phytochemistry. 2000;54(8):979\u2013981.", "ArticleIdList": ["11014301"]}, {"Citation": "Lucena A, et al. The bisindole alkaloid caulerpin, from seaweeds of the genus Caulerpa, attenuated colon damage in murine colitis model. Mar Drugs. 2018;16(9):318.", "ArticleIdList": ["PMC6163434", "30205459"]}, {"Citation": "De Souza \u00c9T, Pereira de Lira D, Cavalcanti de Queiroz A, Costa da Silva DJ, Bezerra de Aquino A, Mella C, Eliane A, Prates Lorenzo V, De Miranda GE, Ara\u00fajo-J\u00fanior D, Xavier J. The antinociceptive and anti-inflammatory activities of caulerpin, a bisindole alkaloid isolated from seaweeds of the genus Caulerpa. MarDrugs. 2009;7:689\u2013704.", "ArticleIdList": ["PMC2810220", "20098607"]}, {"Citation": "Esteves PO, de Oliveira MC, de Souza BC, Cirne-Santos CC, Laneuvlille VT, Palmer Paix\u00e3o IC. Antiviral effect of caulerpin against chikungunya. Nat Prod Commun. 2019;1:1934578X19878295."}, {"Citation": "Lorenzo VP, Barbosa Filho JM, Scotti L, Scotti MT. Combined structure-and ligand-based virtual screening to evaluate caulerpin analogs with potential inhibitory activity against monoamine oxidase B. Rev Bras. 2015;25:690\u2013697."}, {"Citation": "Dassault Syst\u00e8mes BIOVIA Discovery studio modeling environment, release 2017. Dassaul Syst\u00e8mes, San Diego"}, {"Citation": "Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31:455\u2013461.", "ArticleIdList": ["PMC3041641", "19499576"]}, {"Citation": "Raghavendra S, Rao Aditya SJ, Kumar V, Ramesh CK Multiple ligand simultaneous docking (MLSD): a novel approach to study theeffect of inhibitors on substrate binding to PPO. Comput Biol Chem. 10.1016/j.compbiolchem.2015.09.008", "ArticleIdList": ["26414950"]}, {"Citation": "Lipinski CA. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol. 2004;1:337\u2013341.", "ArticleIdList": ["24981612"]}, {"Citation": "Cheng F, Li W, Zhou Y, Shen J, Wu Z, Liu G. admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties. J Chem Inf Model. 2012;52:3099\u20133105. doi: 10.1021/ci300367a.", "ArticleIdList": ["10.1021/ci300367a", "23092397"]}, {"Citation": "Chen X-R, Wang X-T, Hao M-Q, Zhou Y-H, Cui W-Q, Xing X-X, Xu C-G, Bai J-W, Li Y-H Homology modeling and virtual screening to discover potent inhibitors targeting the imidazole glycerophosphate dehydratase protein in Staphylococcus xylosus. Front Chem 5:98. 10.3389/fchem.2017.00098", "ArticleIdList": ["PMC5686052", "29177138"]}, {"Citation": "M\u00e9sz\u00e1ros B, Erd\u0151s G, Doszt\u00e1nyi Z. IUPred2A: context-dependent prediction of protein disorder as a function of redox state and protein binding. Nucleic Acids Res. 2018;2:329\u2013337. doi: 10.1093/nar/gky384.", "ArticleIdList": ["10.1093/nar/gky384", "PMC6030935", "29860432"]}, {"Citation": "Doszt\u00e1nyi Z (2018) Prediction of protein disorder based on IUPred. Protein Sci. 10.1002/pro.3334", "ArticleIdList": ["PMC5734386", "29076577"]}, {"Citation": "Thomas PD, Dill KA. An iterative method for extracting energy-like quantities from protein structures. Proc Natl Acad Sci. 1996;93:11628\u201311633. doi: 10.1073/pnas.93.21.11628.", "ArticleIdList": ["10.1073/pnas.93.21.11628", "PMC38109", "8876187"]}, {"Citation": "Dosztanyi Z, Csizmok V, Tompa P, Simon I. The pairwise energy content estimated from amino acid composition discriminates between folded and intrinsically unstructured proteins. J Mol Biol. 2005;347:827\u2013839. doi: 10.1016/j.jmb.2005.01.071.", "ArticleIdList": ["10.1016/j.jmb.2005.01.071", "15769473"]}, {"Citation": "M\u00e9sz\u00e1ros B, Simon I, Doszt\u00e1nyi Z (2009) Prediction of protein binding regions in disordered proteins. PLoS Comput Biol 5(5). 10.1371/journal.pcbi.1000376", "ArticleIdList": ["PMC2671142", "19412530"]}, {"Citation": "Ortega JT, Serrano ML, Pujol FH, Rangel HR. Unrevealing sequence and structural features of novel coronavirus using in silico approaches: the main protease as molecular target. EXCLI J. 2020;19:400.", "ArticleIdList": ["PMC7081067", "32210741"]}, {"Citation": "Hwang WC, Lin Y, Santelli E, Sui J, Jaroszewski L, Stec B, Farzan M, Marasco WA, Liddington RC. Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R. J Biol Chem. 2006;28:34610\u201334616. doi: 10.1074/jbc.M603275200.", "ArticleIdList": ["10.1074/jbc.M603275200", "PMC7981188", "16954221"]}, {"Citation": "Hughes ZE, Walsh TR. Non-covalent adsorption of amino acid analogues on noble-metal nanoparticles: influence of edges and vertices. Phys Chem Chem Phys. 2016;18:17525\u201317533.", "ArticleIdList": ["27301451"]}, {"Citation": "Ahmed, S. A., Rahman, A. A., Elsayed, K. N., Abd El-Mageed, H. R., Mohamed, H. S., & Ahmed, S. A. (2020). Cytotoxic activity, molecular docking, pharmacokinetic properties and quantum mechanics calculations of the brown macroalga Cystoseira trinodis compounds.\u00a0Journal of Biomolecular Structure and Dynamics, (just-accepted), 1-31.", "ArticleIdList": ["32462976"]}, {"Citation": "Srivastava AK, Tewari M, Shukla HS, Roy BK (2015) In silico profiling of the potentiality of curcumin and conventional drugs for CagA oncoprotein inactivation. Arch Pharm (Weinheim). 10.1002/ardp.201400438", "ArticleIdList": ["25996140"]}]}], "History": [{"Year": "2020", "Month": "4", "Day": "21"}, {"Year": "2020", "Month": "7", "Day": "6"}, {"Year": "2020", "Month": "8", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "25", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "8", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "23"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32837118", "PMC7376526", "10.1007/s11224-020-01586-w", "1586"]}}]}